Selected Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2012

Selected Quarterly Financial Data

The following table provides the selected quarterly financial data for 2012 and 2011 (in thousands, except per share amounts):

SOLAZYME, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Quarter Ended
	December 31, 2012			September 30, 2012			June 30, 2012			March 31, 2012			December 31, 2011			September 30, 2011			June 30, 2011			March 31, 2011
Revenues:
Research and development programs	$	3,811		$	4,810		$	9,468		$	9,560		$	8,251		$	7,051		$	6,092		$	5,399
Product revenue		4,613			3,773			4,077			3,996			1,638			1,886			1,306			2,343
License fees		—			—			—			—			5,000			—			—			—
Total revenues		8,424			8,583			13,545			13,556			14,889			8,937			7,398			7,742
Costs and operating expenses:
Cost of product revenue		1,404			1,331			1,330			1,246			828			554			374			664
Research and development		16,108			16,534			18,381			15,361			16,921			10,866			9,676			8,150
Sales, general and administrative		15,888			13,849			13,723			14,056			12,835			11,527			10,955			6,109
Total costs and operating expenses		33,400			31,714			33,434			30,663			30,584			22,947			21,005			14,923
Loss from operations		(24,976	)		(23,131	)		(19,889	)		(17,107	)		(15,695	)		(14,010	)		(13,607	)		(7,181	)
Other income (expense):
Interest and other income (expense), net		249			626			309			327			114			(76	)		(184	)		375
Loss from equity method investment		(631	)		(683	)		(510	)		—			—			—			—			—
Gain (loss) from change in fair value of warrant liability		748			685			851			—			—			—			(3,154	)		(483	)
Total other income (expense)		366			628			650			327			114			(76	)		(3,338	)		(108	)
Net loss		(24,610	)		(22,503	)		(19,239	)		(16,780	)		(15,581	)		(14,086	)		(16,945	)		(7,289	)
Accretion of redeemable convertible preferred stock		—			—			—			—			—			—			(24	)		(36	)
Net loss attributable to Solazyme, Inc. common stockholders	$	(24,610	)	$	(22,503	)	$	(19,239	)	$	(16,780	)	$	(15,581	)	$	(14,086	)	$	(16,969	)	$	(7,325	)
Net loss per share attributable to Solazyme, Inc. common stockholders:
Basic and diluted	$	(0.40	)	$	(0.37	)	$	(0.32	)	$	(0.28	)	$	(0.26	)	$	(0.24	)	$	(0.61	)	$	(0.60	)
Weighted-average number of shares used in loss per share computation:
Basic and diluted		60,873			60,678			60,378			60,101			59,703			59,508			27,673			12,160